3.6300
-0.0800
(-2.16%)
At close: January 10 at 4:00:02 PM EST
4.2500
+0.62
+(17.08%)
After hours: 7:07:30 PM EST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 1 | 2 |
Avg. Estimate | -1.25 | -1.25 | 1.29 | 2.5 |
Low Estimate | -1.25 | -1.25 | 1.29 | 1.25 |
High Estimate | -1.25 | -1.25 | 1.29 | 3.75 |
Year Ago EPS | -- | -1.25 | -5.97 | 1.29 |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 3 | 3 | 1 | 3 |
Avg. Estimate | 7.06M | 9.15M | 92.1M | 125.2M |
Low Estimate | -- | -- | 92.1M | 57.3M |
High Estimate | 21.18M | 22.1M | 92.1M | 250.53M |
Year Ago Sales | -- | -- | -- | 92.1M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 35.95% |
Earnings History
Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
---|---|---|---|---|
EPS Est. | -- | -1.5 | -1.12 | -1.5 |
EPS Actual | -1.5 | -1.25 | -1.5 | -5.8 |
Difference | -- | 0.25 | -0.38 | -4.3 |
Surprise % | -- | 16.67% | -33.33% | -286.67% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | -1.25 | -1.25 | 1.29 | 2.5 |
7 Days Ago | 0 | 0 | 1.29 | 2.5 |
30 Days Ago | 0 | 0 | 0.12 | 10.12 |
60 Days Ago | 0 | 0 | 3.5 | 19 |
90 Days Ago | 0 | 0 | 3.5 | 19 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | 1 | 1 |
Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
CTXR | -- | 0.00% | 121.61% | 93.80% |
S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Upgrades & Downgrades
Downgrade | D. Boral Capital: Buy to Hold | 11/22/2024 |
Reiterates | HC Wainwright & Co.: Buy to Buy | 11/12/2024 |
Maintains | D. Boral Capital: Buy to Buy | 11/11/2024 |
Maintains | EF Hutton: Buy to Buy | 8/19/2024 |
Maintains | EF Hutton: Buy to Buy | 8/8/2024 |
Maintains | EF Hutton: Buy to Buy | 8/5/2024 |
Related Tickers
CVM CEL-SCI Corporation
0.4252
+16.05%
ATOS Atossa Therapeutics, Inc.
0.9037
-2.27%
EYEN Eyenovia, Inc.
0.1080
-9.77%
TNXP Tonix Pharmaceuticals Holding Corp.
0.2787
+8.87%
CRMD CorMedix Inc.
11.19
+3.52%
GRCE Grace Therapeutics, Inc.
4.1900
+0.96%
IBIO iBio, Inc.
2.5500
-6.25%
BLRX BioLineRx Ltd.
0.1429
+0.21%
CHRS Coherus BioSciences, Inc.
1.4700
-2.65%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%